Thunderbolt Pharma

Eight Months After First FDA Approval, Aurinia Picks Up Two More Candidates
BioSpace
Tue, 08/17/21 - 10:40 pm
Aurinia Pharmaceuticals
autoimmune disease
Thunderbolt Pharma
M&A